Our Story and Vision: From stars to cells
Significant medical breakthroughs often originate outside medicine. Ours comes from astrophysics.
Mauna Kea Technologies’ founder, Sacha Loiseau, Ph.D ., built his early career in astrophysics . Together with a multi-disciplinary team of the top minds in physics, mathematics, astrophysics and imaging, he worked on some of the most challenging astronomical projects at NASA , including the development of technologies to generate clear images of the faintest objects millions of miles from earth. Having seen the imaging of the universe’s farthest frontiers become a reality, he turned to his lifelong interest in medical imaging and dedicated himself to finding a way to clearly visualize the smallest, darkest areas insides the body’s organs. He brought together a multi-disciplinary team of experts and founded the company with the highest confidence that the advances in astrophysics instrumentation could be applied to medicine to detect disease and help patients get the right treatments faster than ever possible before.
For decades, tissue has been the issue, because biopsy - the physical removal of a piece of tissue - was the only way to get access to the microscopic information which reveals the exact nature of the tissue and enables a diagnostic assessment. Limited sampling, delays associated with the histopathological evaluation of the biopsy specimens, and complications originating from biopsies, were inherent limitations to the process faced everyday by patients and physicians alike.
With Cellvizio, optical biopsy has brought the microscope to the patient, literally inside the patient, thus providing critical benefits to patients and physicians: real time evaluation of live tissue at the finest level, with immediate results rather than days or weeks later, the ability to examine as many areas as necessary during a procedure, the absence of any complications due to the biopsy.
Our vision is that the establishment of optical biopsy procedures with confocal laser endomicroscopy and its future developments is dramatically enhancing the patient management, by streamlining the diagnosis work-up, making it faster, more reliable and more cost-effective.